natgillin/translations-raw huggingface dataset:
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street, Ware, Hertfordshire, SG 12 0DJ, United Kingdom.
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street, Ware, Hertfordshire, SG 12 0DJ, Ujedinjeno Kraljevstvo
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street, Ware, Hertfordshire, SG12 0DJ, United Kingdom
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street, Ware, Hertfordshire, SG12 0DJ, Ujedinjeno Kraljevstvo
Glaxo Operations UK Ltd. (trading as Glaxo Wellcome Operations) Priory Street‌
Glaxo Operations UK Ltd. (posluje kao Glaxo Wellcome Operations) Priory Street
Glaxo Wellcome Operations, Priory Street, Ware, Hertfordshire SG12 0DJ, United Kingdom
Glaxo Wellcome Operations, Priory Street, Ware, Hertfordshire SG12 0DJ, Velika Britanija
Glaxo Wellcome S.A., Avenida de Extremadura 3, 09400 Aranda de Duero Burgos, Spain Oral suspension
Glaxo Wellcome S.A., Avenida de Extremadura 3, 09400 Aranda de Duero Burgos, Španjolska Oralna suspenzija
Glaxo Wellcome, S.A., Avda.
Glaxo Wellcome S.A., Avda.
GlaxoSmithKline (Cyprus) Ltd
GlaxoSmithKline (Cyprus ) Ltd
GlaxoSmithKline (Cyprus) Ltd Τηλ: + 357 22 39 70 00
GlaxoSmithKline S.p.A. Tel:+ 39 04 59 21 81 11
GlaxoSmithKline (GSK) SRL Tel: +40 (0)21 3028 208
GlaxoSmithKline (GSK) S.R.L. Tel: +40 (0)21 3028 208
GlaxoSmithKline (Ireland) Ltd Tel: + 353 (0)1 4955000
Tel: + 385 1 6015999
GlaxoSmithKline (Malta) Limited Tel: + 356 21 238131
GlaxoSmithKline Malta Limited Tel: + 356 21 238131
GlaxoSmithKline A.E.B.E Tηλ: + 30 210 68 82 100
GlaxoSmithKline A.E.B.E
GlaxoSmithKline A.E.B.E. Tηλ: + 30 210 68 82 100
GlaxoSmithKline A.E.B.E. Τηλ: + 30 210 68 82 100
GlaxoSmithKline Biologicals S.A. 89, rue de l’Institut – 1330 Rixensart Belgium
GlaxoSmithKline Biologicals S.A. 89, rue de l’Institut – 1330 Rixensart Belgija
GlaxoSmithKline Biologicals SA Parc de la Noire Epine rue Flemming 20-1300 Wavre Belgium
GlaxoSmithKline Biologicals SA Parc de la Noire Epine rue Flemming 20-1300 Wavre Belgija
GlaxoSmithKline Eesti OÜ Tel: +372 667 6900 estonia@gsk.com
GlaxoSmithKline Eesti OU Tel: + 372 667 6900 estonia@gsk.com
GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com
GlaxoSmithKline (Cyprus) Ltd Τηλ: + 357 22 39 70 00
GlaxoSmithKline Lietuva UAB Tel. +370 5 264 90 00 info.lt@gsk.com
GlaxoSmithKline Lietuva UAB Tel: + 370 5 264 90 00 info.lt@gsk.com
GlaxoSmithKline Pharmaceuticals S.A., ul., Grunwaldzka 189, 60-322 Poznan, Poland.
GlaxoSmithKline Pharmaceuticals S.A., ul., Grunwaldzka 189, 60-322 Poznan, Poljska
GlaxoSmithKline S.p.A. Tel:+ 39 04 59 21 81 11
Sími: +354 530 3700
GlaxoSmithKline Trading Services Limited, Currabinny, Carrigaline, County Cork, Ireland
GlaxoSmithKline Trading Services Limited, Currabinny, Carrigaline, County Cork, Irska
Glenmark Pharmaceuticals Europe Limited Laxmi House, 2-B Draycott Avenue, Kenton, Harrow, Middlesex, HA3 OBU, United Kingdom
Glenmark Pharmaceuticals Europe Limited Laxmi House, 2-B Draycott Avenue, Kenton, Harrow, Middlesex, HA3 OBU, Velika Britanija
glibenclamide, metformin, repaglinide – used to treat diabetes
glibenklamid, metformin, repaglinid – koriste se za liječenje šećerne bolesti
Glibenclamide: co-administration of bosentan 125 mg twice daily for 5 days decreased the plasma concentrations of glibenclamide (a CYP3A4 substrate) by 40%, with potential significant decrease of the hypoglycaemic effect.
Glibenklamid: istodobna primjena bosentana 125 mg dvaput dnevno tijekom 5 dana smanjila je koncentraciju glibenklamida u plazmi (supstrat za CYP3A4) za 40%, s mogućim značajnim smanjenjem hipoglikemijskog učinka.
Glidipion 15 mg tablets are white, round, flat, bevelled, 5.5 mm in diameter and engraved with ‘TZ15’ on one side.
Glidipion 15 mg tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 5,5 mm s utisnutom oznakom ‘TZ15’ na jednoj strani.
Glidipion 15 mg, 30 mg and 45 mg tablets Glidipion 15 mg tablets Glidipion 30 mg tablets Glidipion 45 mg tablets
Glidipion 15 mg, 30 mg i 45 mg tablete Glidipion 15 mg tablete Glidipion 30 mg tablete Glidipion 45 mg tablete
Glidipion 30 mg tablets are white, round, flat, bevelled, 7 mm in diameter and engraved with ‘TZ30’ on one side.
Glidipion 30 mg tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 7 mm s utisnutom oznakom ‘TZ30’ na jednoj strani.
Glidipion 45 mg tablets are white, round, flat, bevelled, 8 mm in diameter and engraved with ‘TZ45’ on one side.
Glidipion 45 mg tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 8 mm s utisnutom oznakom ‘TZ45’ na jednoj strani.
Glidipion with food and drink
Glidipion s hranom i pićem
glimepiride (N=132)
glimepirid (N=132)
Glimepiride (titrated) + metformin (N = 482)
Placebo + inzulin (N = 565)
Glimepiride 2 to 4 mg daily + Metformin
Glimepirid 2-4 mg na dan + metformin
Glimepiride 4 mg/day
Glimepirid 4 mg/dan
Glimepiride 8 mg/day
Glimepirid 8 mg/dan
Glimepiride has a very low distribution volume (approximately 8.8 litres) which is roughly equal to the albumin distribution space, high protein binding (> 99%), and a low clearance (approximately 48 ml/min).
Glimepirid ima vrlo mali volumen distribucije (približno 8,8 litara), koji otprilike odgovara prostoru distribucije albumina, u visokom se postotku veže za proteine (> 99%) i ima niski klirens (približno 48 ml/min).
Gliolan 30 mg/ml powder for oral solution.
Gliolan 30 mg/ml prašak za oralnu otopinu.
Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (WHO grade III and IV).
Gliolan je indiciran u odraslih bolesnika za vizualizaciju zloćudnog tkiva tijekom kirurškog liječenja zloćudnog glioma (stupanj III i IV prema Svjetskoj zdravstvenoj organizaciji [SZO]).
Gliolan is provided in a glass vial and presented in packs of 1, 2 and 10 vials.
Gliolan se isporučuje u staklenoj bočici u pakiranjima od 1, 2 i 10 bočica.
Glipizide
Glipizid
Glipizide or other “sulfonylureas” (used to treat high blood sugar)
digoksin (primjenjuje se za liječenje zatajenja srca), glipizid ili druge sulfonilureje (primjenjuju se za liječenje povišenog šećera u krvi).
Glipizide or other “sulfonylureas” (used to treat high blood sugar).
digoksin (primjenjuje se za liječenje zatajenja srca), glipizid ili druge sulfonilureje (primjenjuju se za liječenje povišenog šećera u krvi).
Glivec (imatinib) 400 mg once daily n=283 (%)
Glivec (imatinib) 400 mg jedanput na dan n=283 (%)
Glivec 100 mg capsules are orange to greyish-orange and marked “NVR SI”.
Glivec 100 mg kapsule su narančaste do sivkastonarančaste, s oznakom „NVR SI“.
Glivec 100 mg capsules Imatinib
Glivec 100 mg tvrde kapsule imatinib
Glivec 100 mg film-coated tablets are very dark yellow to brownish-orange round tablets.
Glivec 100 mg filmom obložene tablete su jako tamnožute do smećkastonarančaste okrugle tablete.
Glivec 100 mg film-coated tablets Imatinib
Glivec 100 mg filmom obložene tablete imatinib
Glivec 100 mg hard capsules Imatinib
Glivec 100 mg tvrde kapsule imatinib
Glivec 100 mg tablets Imatinib
Glivec 100 mg filmom obložene tablete imatinib
Glivec 400 mg film-coated tablets are very dark yellow to brownish-orange oval tablets.
Glivec 400 mg filmom obložene tablete su jako tamnožute do smećkastonarančaste ovalne tablete.
Glivec 400 mg film-coated tablets Imatinib
Glivec 400 mg filmom obložene tablete imatinib
Glivec 400 mg tablets Imatinib
Glivec 400 mg filmom obložene tablete imatinib
Glivec 50 mg capsules are light yellow to orange-yellow and marked “NVR SH”.
Glivec 50 mg kapsule su svijetložute do narančastožute, s oznakom „NVR SH“.
Glivec 50 mg capsules Imatinib
Glivec 50 mg tvrde kapsule imatinib
Glivec 50 mg hard capsules
Glivec 50 mg tvrde kapsule
Glivec 50 mg hard capsules Imatinib
Glivec 50 mg tvrde kapsule imatinib
Glivec is indicated for the treatment of adult and paediatric patients with newly diagnosed Philadelphia chromosome (bcr-abl) positive (Ph+) chronic myeloid leukaemia (CML) for whom bone marrow transplantation is not considered as the first line of treatment. adult and paediatric patients with Ph+ CML in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. adult and paediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) integrated with chemotherapy. adult patients with relapsed or refractory Ph+ ALL as monotherapy. adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements. adult patients with advanced hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) with FIP1L1-PDGFR rearrangement.
Glivec je indiciran za liječenje odraslih i pedijatrijskih bolesnika s novodijagnosticiranom kroničnom mijeloičnom leukemijom (KML) s pozitivnim Philadelphia (Ph+) kromosomom (bcr-abl), u kojih se transplantacija koštane srži ne smatra prvom linijom liječenja. odraslih i pedijatrijskih bolesnika s Ph+ KML-om u kroničnoj fazi nakon neuspjeha terapije interferonom-alfa, ili u ubrzanoj fazi ili u blastičnoj krizi. odraslih i pedijatrijskih bolesnika s novodijagnosticiranom akutnom limfoblastičnom leukemijom s pozitivnim Philadelphia kromosomom (Ph+ ALL) uz kemoterapiju. odraslih bolesnika s recidivirajućim ili refraktornim Ph+ ALL-om u obliku monoterapije. odraslih bolesnika s mijelodisplastičnim/mijeloproliferativnim bolestima (MDS/MPD) povezanim s preraspodjelom gena za receptor za faktor rasta koji potječe od trombocita (PDGFR). odraslih bolesnika s uznapredovalim hipereozinofilnim sindromom (HES) i/ili kroničnom eozinofilnom leukemijom (KEL) s FIP1L1-PDGFR preraspodjelom.
Glivec is indicated for the treatment of adult patients with Kit (CD 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST). the adjuvant treatment of adult patients who are at significant risk of relapse following resection of Kit (CD117)-positive GIST.
Glivec je indiciran za liječenje odraslih bolesnika s Kit (CD 117) pozitivnim inoperabilnim i/ili metastazirajućim malignim gastrointestinalnim stromalnim tumorima (GIST). adjuvantno liječenje odraslih bolesnika s visokim rizikom od recidiva bolesti nakon resekcije Kit (CD117)-pozitivnog GIST-a.
Glivec is not recommended during pregnancy unless clearly necessary as it may harm your baby.
Glivec se ne smije upotrebljavati tijekom trudnoće, osim ako to nije neophodno.
Glivec should not be used during pregnancy unless clearly necessary.
Glivec se ne smije primjenjivati u trudnoći osim ako njegova primjena nije izrazito neophodna.
Glivec vs placebo
Glivec vs. placebo
Global health status / health-related quality of life by patient-report were measured using the EORTC Quality of Life Questionnaire – Core 30 (QLQ-C30).
Opći zdravstveni status / kvaliteta života vezana uz zdravlje koje su prijavljivali bolesnici određivali su se na temelju upitnika za ocjenu kvalitete života EORTC – Core 30 (QLQ-C30).
Global Response of Success at EOIVTb
Opći odgovor uspjeha pri EOIVTb
Global Response of Success at EOTb
Opći odgovor uspjeha pri EOTb
Global success in the MITT population: primary and secondary endpoints
Opći uspjeh liječenja u MITT populaciji: primarni i sekundarni ishodi
Globally, the adverse reactions reported in the compassionate use program and in literature concerned hypoglycemia (and related event like hypoglycaemic seizure) and aggravated respiratory tract infections with respiratory distress.
Sveukupno gledano, nuspojave zabilježene u programu uporabe suosjećanja i u literaturi po pitanju hipoglikemije (i događaja srodnih hipoglikemijskim napadajima) i teških infekcija dišnih puteva s dišnim tegobama.
glomerular filtration rate (CrCL,)
Brzina glomerularne filtracije (CrCL,)
Glomerular filtration rate decreased
smanjena brzina glomerularne filtracije
Glomerulonephri tis
Glomerulonefrit is
Glomerulonephritis
astenijaa
Glomerulonephritis
dispneja
Glomerulonephritis
glomerulo- nefritis
Glomerulonephritis
Glomerulonefriti s
Glomerulonephritis
proteinurija
Glomerulonephritis has been reported in patients receiving filgrastim and pegfilgrastim.
Glomerulonefritis je prijavljen kod bolesnika koji primaju filgrastim i pegfilgrastim.
Glomerulonephritis membranous
makulopapularni osip
Glomerulonephritis membranous
membranski glomerulonefritis
Glomerulonephritis, blood creatinine increased
Glomerulonefritis, povećanje kreatinina u krvi
Glomerulonephropathy
glomerulonefropatija
Glomerulonephropathy
pruritus
Glomerulonephropathy was reported in rats at exposure levels 3 to 5 fold higher than the clinical AUC after 6 dosing cycles of clofarabine.
U štakora je prijavljena glomerulonefropatija kod razina izloženosti 3 do 5 puta većih od kliničkog AUC- a nakon 6 ciklusa klofarabina.
Glossodynia
glosodinija
Gloves must be worn when removing IONSYS from the patient’s skin and during disposal.
Potrebno je nositi rukavice kada se IONSYS uklanja s kože bolesnika i tijekom zbrinjavanja.
Gloves should be worn during the assembly of IONSYS.
Prilikom sastavljanja sustava IONSYS moraju se nositi rukavice.
Gloves should be worn during the assembly/handling of IONSYS.
Potrebno je nositi rukavice tijekom sastavljanja/rukovanja sustavom IONSYS.
Gloves should be worn when manipulating IONSYS.
Prilikom rukovanja sustavom IONSYS moraju se nositi rukavice.
Gloves: for hands, wrist and fingers.
Rukavice: za šake, zapešća i prste.
GLP­1 is a physiological regulator of appetite and food intake, but the exact mechanism of action is not entirely clear.
GLP-1 je fiziološki regulator apetita i unosa hrane, no točan mehanizam njegovog djelovanja nije potpuno jasan.
Glubrava 15 mg/850 mg film-coated tablets
Glubrava 15 mg/850 mg filmom obložene tablete
Glubrava 15 mg/850 mg film-coated tablets Pioglitazone/Metformin hydrochloride
Glubrava 15 mg/850 mg filmom obložene tablete pioglitazon/metforminklorid
Glubrava 15 mg/850 mg tablets Pioglitazone/Metformin hydrochloride
Glubrava 15 mg/850 mg tablete
Glubrava combines two antihyperglycaemic active substances with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: pioglitazone, a member of the thiazolidinedione class and metformin hydrochloride, a member of the biguanide class.
Glubrava je kombinacija dvije antihiperglikemijske djelatne tvari s komplementarnim mehanizmom djelovanja koje poboljšavaju kontrolu glikemije u bolesnika sa šećernom bolešću tipa 2: pioglitazonom iz klase tiazolidindiona i metforminkloridom iz klase bigvanida.
Glubrava is used in adults (particularly those who are overweight) who have type 2 diabetes.
Lijek Glubrava primjenjuje se u odraslih osoba (osobito onih s prekomjernom tjelesnom težinom) koje imaju dijabetes tipa 2.
Glubrava is used in patients who are not satisfactorily controlled on metformin (a diabetes medicine) used on its own and at the maximum possible dose.
Lijek Glubrava primjenjuje se u bolesnika koji ne mogu postići zadovoljavajuću kontrolu samo metforminom (lijekom za liječenje dijabetesa) u najvišim podnošljivim dozama.
Glubrava tablets are white to off white, oblong, convex, film-coated tablets (tablets) embossed ‘15 / 850’ on one face and ‘4833M’ on the other.
Tablete Glubrava su bijele do gotovo bijele boje, ovalne, konveksne filmom obložene tablete (tablete) s utisnutim „15 / 850“ na jednoj strani i „4833M“ na drugoj.
glucagon (pancreas hormone used to treat severe hypoglycaemia),
glukagon (hormon gušterače, koristi se za liječenje teške hipoglikemije)
glucagon (pancreas hormone used to treat severe hypoglycaemia),
glukagon (hormon gušterače, koristi se za liječenje teške hipoglikemije),
glucagon (pancreas hormone used to treat severe hypoglycaemia),
glukagon (hormon gušterače, koristi za liječenje teške hipoglikemije),
Glucagon – for very low blood sugar.
glukagon – koristi za liječenje vrlo niske razine šećera u krvi
glucagon(pancreas hormone used to treat severe hypoglycaemia),
glukagon (hormon gušterače, koristi za liječenje teške hipoglikemije),
glucocorticoid, which is not a
toga, ne preporučuje se istodobna
Glucocorticoids (anti-inflammation medicines that dampen down your immune system) since the simultaneous use of glucocorticoids and asparaginase may increase the formation of blood clots (thrombosis).
Glukokortikoidi (protuupalni lijekovi koji smanjuju odgovor imunosnog sustava) jer istovremena primjena glukokortikoida i asparaginaze može povećati stvaranje krvnih ugrušaka (tromboza).
glucocorticoids (e.g. beclometasone, prednisolone) steroid medicines used to treat inflammation in conditions such as severe asthma, arthritis
glukokortikoide (npr. beklometazon, prednizolon), steroidne lijekove kojima se liječi upala u stanjima kao što su teška astma, artritis
Glucocorticoids (given by systemic and local routes), beta-2-agonists and diuretics (see also section 4.4) have intrinsic hyperglycaemic activity.
Glukokortikoidi (primijenjeni sistemskim ili lokalnim putem), beta-2-agonisti i diuretici (vidi također dio 4.4) imaju intrinzičku hiperglikemijsku aktivnost.
Glucocorticoids (given by systemic and local routes), beta-2-agonists, and diuretics have intrinsic hyperglycaemic activity.
Glukokortikoidi (primijenjeni sistemskim ili lokalnim putem), beta-2 agonisti i diuretici imaju intrinzičnu hiperglikemijsku aktivnost.
glucocorticoids (hydrocortisone, dexamethasone);
glukokortikoidi (hidrokortizon, deksametazon);
GLUCOCORTICOIDS (INHALED)
GLUKOKORTIKOIDI (INHALACIJSKI)
Glucocorticoids (such as ‘cortisone’ used to treat inflammation)
glukokortikoide (poput kortizona, koriste se za liječenje upale)
glucocorticoids (to treat allergies and inflammation)
glukokortikoidi (za liječenje alergija i upala)
glucocorticoids (to treat allergies and inflammation)
glukokortikoidi (za liječenje alergija i upale)
glucocorticoids (used to treat inflammation)
glukokortikoidi (primjenjuju se za liječenje upale)
Glucocorticoids and/ or anticoagulants
Glukokortikoidi i/ili antikoagulansi
glucocorticoids generally used to treat inflammation
glukokortikoide koji se obično koriste za liječenje upala
glucocorticoids progressive dose
nadmašuje rizik od učinaka
glucocorticoids such as ‘cortisone’ - for inflammation
glukokortikoide poput ‘kortizona’ - za upalu
glucocorticoids such as ‘cortisone’ – for inflammation
glukokortikoide poput ‘kortizona’ - za upalu
Glucocorticoids, salicylates, nonsteroidal anti-inflammatory drugs, or analgesics can be continued during treatment with Humira.
Za vrijeme liječenja lijekom Humira može se nastaviti s davanjem glukokortikoida, salicilata, nesteroidnih protuupalnih lijekova ili analgetika.
Glucocorticoids: Concomitant use of boosted saquinavir and fluticasone or other glucocorticoids that are metabolised by CYP3A4 is not recommended unless the potential benefit of treatment outweighs the risk of systemic corticosteroid effects, including Cu’hing's syndrome and adrenal suppression (see section 4.5).
Glukokortikoidi: Ne preporučuje se istodobna primjena sakvinavira pojačanog potpornim lijekom i flutikazona ili drugih glukokortikoida koji se metaboliziraju putem CYP3A4, osim ako potencijalna korist liječenja ne nadmašuje rizike od sustavnih učinaka kortikosteroida, uključujući Cushingov sindrom i supresiju nadbubrežnih žlijezda (vidjeti dio 4.5).
Glucodynamic differences between insulin lispro and soluble human insulin, as measured during a glucose clamp procedure, were maintained over a wide range of renal function.
Glukodinamičke razlike između inzulina lispro i topljivog humanog inzulina, određene "clamp" tehnikom, održane su u različitim stupnjevima bubrežne funkcije.
GLUCOSE - mg/dL
GLUKOZA- mg/dL
glucose 50 mg/ml (5%) solution for infusion sodium chloride 4.5 mg/ml (0.45%) and glucose 50 mg/ml (5%) solution for injection/infusion
otopina glukoze 50 mg/ml (5%) za infuziju otopina natrijevog klorida 4,5 mg/ml (0,45%) i glukoze 50 mg/ml (5%) za injekciju/infuziju
glucose 50 mg/ml (5%) solution for infusion; or sodium chloride 4.5 mg/ml (0.45%) and glucose 50 mg/ml (5%) solution for injection/infusion.
otopina glukoze 50 mg/ml (5%) za infuziju; otopina natrijevog klorida 4,5 mg/ml (0,45%) i glukoze 50 mg/ml (5%) za injekciju/infuziju; ili
glucose 50 mg/ml (5%) solution for infusion; sodium chloride 4.5 mg/ml (0.45%) and glucose 50 mg/ml (5%) solution for injection/infusion; or
otopina glukoze 50 mg/ml (5%) za infuziju; ili otopina natrijevog klorida 4,5 mg/ml (0,45%) i glukoze 50 mg/ml (5%) za injekciju/infuziju.
Glucose anhydrous Dispersible cellulose Polysorbate 80 Benzalkonium chloride Disodium edetate Purified water
glukoza, bezvodna celuloza, disperzibilna polisorbat 80 benzalkonijev klorid dinatrijev edetat voda, pročišćena
Glucose control
Kontrola razine glukoze
Glucose in urine, increased urine volume and frequency
šećer u mokraći, povećan volumen mokraće i učestalost mokrenja
Glucose Infusion Rate
Brzina infuzije glukoze
glucose is recommended.
Mikofenolna kiselina (jedna
Glucose liquid spray dried Sodium
Raspršina tekuće glukoze Natrij
Glucose monohydrate Povidone
Glukoza monohidrat Povidon
glucose urine present
prisutnost glukoze u urinu
Glucose-6-phosphate dehydrogensae deficiency
deficit glukoza-6-fosfat-dehidrogenaze
Glucose-monitoring is to be intensified and the insulin dose adjusted on an individual basis (see section 5.2).
Treba pojačano pratiti razinu glukoze te individualno prilagoditi dozu inzulina (vidjeti dio 5.2).
Glucosuria
Glukozurija
Glucosuria Increased appetite
Glukozurija Povećani apetit
Glucuronidation disorder like Gilbert’s syndrome
Poremećaj glukuronidacije poput Gilbertovog sindroma
Glucuronidation is the major metabolic pathway for both eslicarbazepine and lamotrigine and therefore, an interaction could be expected.
Glukuronidacija je glavni metabolički put za eslikarbazepin i lamotrigin i stoga se mogu očekivati interakcije.
Glucuronide metabolites  
Glukuronidni metaboliti  
gluing tissues together
pajanja tkiva lijepljenjem
gluing tissues together
pajanje tkiva lijepljenjem
GLULISINE - pre REGULAR - pre
VRIJEME - sati
Glustin 15 mg tablets are white to off-white, round, convex tablets marked “15” on one face, “AD4” on the other.
Glustin 15 mg tablete su bijele do gotovo bijele boje, okrugle, konveksne, s oznakom ‘15’ na jednoj strani i ‘AD4’ na drugoj strani.
Glustin 15 mg tablets Glustin 30 mg tablets Glustin 45 mg tablets
Glustin 15 mg tablete Glustin 30 mg tablete Glustin 45 mg tablete
Glustin 15 mg Tablets Glustin 30 mg Tablets Glustin 45 mg Tablets Pioglitazone
Glustin 15 mg tablete Glustin 30 mg tablete Glustin 45 mg tablete pioglitazon
Glustin 15 mg tablets Pioglitazone
Glustin 15 mg tablete pioglitazon
Glustin 30 mg tablets are white to off-white, round, flat tablets marked “30” on one face, “AD4” on the other.
Glustin 30 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate, s oznakom ‘30’ na jednoj strani i ‘AD4’ na drugoj strani.
Glustin 30 mg tablets Pioglitazone
Glustin 30 mg tablete pioglitazon
Glustin 45 mg tablets are white to off-white, round, flat tablets marked “45” on one face, “AD4” on the other.
Glustin 45 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate, s oznakom ‘45’ na jednoj strani i ‘AD4’ na drugoj strani.
Glustin 45 mg tablets Pioglitazone
Glustin 45 mg tablete pioglitazon
Glustin led to a decrease in the level of HbA1c, indicating that blood glucose levels had been reduced at doses of 15, 30 and 45 mg.
Lijek Glustin smanjio je razinu tvari HbA1c, što pokazuje da su razine glukoze u krvi smanjene na doze od 15, 30 i 45 mg.
Glustin on its own was shown to be as effective as metformin and gliclazide.
Lijek Glustin kao monoterapija pokazao se jednako djelotvornim kao metmorfin i gliklazid.
Glustin tablets contain lactose monohydrate and therefore should not be administered to patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption.
Tablete Glustin sadrže laktozu hidrat te se stoga ne smiju primjenjivati u bolesnika s rijetkim nasljednim poremećajima nepodnošenja galaktoze, nedostatka Lapp laktaze ili malapsorpcijom glukoze-galaktoze.
Glustin with food and drink
Glustin s hranom i pićem
Glutamyltransferase
gama glutamiltransferaz e10,
glutamyltransferase
glutamil
Glutamyltransferase
glutamiltransferaza1
glutamyltransferase
toksična